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Heleen A Reinders-Messelink1,5 and Hermien E K de Walle3Abstract
Background: Reported birth prevalences of congenital limb defects (CLD) vary between countries: from 13/10,000
in Finland for the period 1964–1977 to 30.4/10,000 births in Scotland from 1964–1968. Epidemiological studies
permit the timely detection of trends in CLD and of associations with other birth defects. The aim of this study is to
describe the birth prevalence of CLD in the northern Netherlands.
Methods: In a population-based, epidemiological study we investigated the birth prevalences of CLD for 1981–2010.
Data were collected by the European Surveillance of Congenital Anomalies in the northern Netherlands
(EUROCAT-NNL). We excluded malpositions, club foot, and dislocation/dysplasia of hips or knees. Trends were analysed
for the 19-year period 1992–2010 using χ2 tests, as well as CLD association with anomalies affecting other organs.
Results: The birth prevalence of CLD was 21.1/10,000 births for 1981–2010. There was an overall decrease in
non-syndromic limb defects (P = 0.023) caused by a decrease in the prevalence of non-syndromic syndactyly (P < 0.01)
in 1992–2010. Of 1,048 children with CLD, 55% were males, 57% had isolated defects, 13% had multiple congenital
anomalies (MCA), and 30% had a recognised syndrome. The upper:lower limb ratio was 2:1, and the left:right side ratio
was 1.2:1. Cardiovascular and urinary tract anomalies were common in combination with CLD (37% and 25% of cases
with MCA). Digestive-tract anomalies were significantly associated with CLD (P = 0.016).
Conclusions: The birth prevalence of CLD in the northern Netherlands was 21.1/10,000 births. The birth prevalence of
non-syndromic syndactyly dropped from 5.2/10,000 to 1.1/10,000 in 1992–2010.
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Limb defects seen in childhood are mainly congenital
and occur when a part of or the entire limb fails to form
normally during pregnancy. Reduction defects may be
disabling limb defects due to the failure of several ele-
ments to form properly [1]. Less disabling limb defects
are polydactyly, defined as complete or partial super-
numerary digits, and syndactyly, fusion of two or more
digits [2]. Disruptive events appear to be the most com-
mon cause of congenital limb defects (CLD) [3]. During
the gestational period, disruptive events, such as amniotic* Correspondence: e.golea.vasluian@umcg.nl
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reproduction in any medium, provided the orband or vascular disruptions, may cause amputation or
hypoperfusion of the developing limbs [4]. Various CLD
are due to prenatal exposure to different teratogens [5],
the best-known example of which is thalidomide, which
caused a wide range of CLD, especially intercalary reduc-
tions and preaxial defects, in the 1960s [6]. To prevent
further tragedies, several international registries of con-
genital defects were established. The European Surveil-
lance of Congenital Anomalies (EUROCAT) network of
registries in thirty-seven countries and the International
Clearinghouse for Birth Defects Surveillance and Research
are two such registries that have the goal of monitoring
birth defects [7,8]. Monitoring CLD birth prevalences (BP)
permits estimates of how common CLD are in the general
population, early detection of risk factors for CLD and itsl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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parison of standard data collections.
Complete epidemiological descriptions of all CLD in dif-
ferent countries are rather scarce. In Finland a BP of 13/
10,000 births was found for the period 1964–1977, whereas
in Scotland it was estimated at 30/10,000 for 1964–1968
[9,10]. More common reports in the literature are studies
on specific types of CLD, especially of congenital reduction
defects [11-22]. Reported BPs of reduction defects vary
widely in time, and between countries. In Italy the preva-
lence was as low as 4.8/10,000, while in France it was 10.4/
10,000 from 1979–1987 [13,23,24]. The BP/10,000 of CLD
in the Netherlands from 1997–2007 was 9.9 for polydactyly,
7.0 for syndactyly and 1.4 for reduction defects [25].
There is no up-to-date, detailed information on CLD
in the Dutch population available. Therefore, the aim of
this study is to describe the epidemiology of CLD in a




The CLD cases have been collected by EUROCAT in the
northern Netherlands (EUROCAT-NNL) since 1981.
Children or foetuses with one or more major congenital
defects and whose mothers lived in the northern prov-
inces (Groningen, Drenthe or Friesland) at the time of
delivery were eligible for registration.
Cases were ascertained according to EUROCAT’s Cen-
tral Registry guidelines [26]. EUROCAT-NNL registers
foetuses irrespective of gestational age, spontaneous abor-
tions, terminations of pregnancies (foetuses of ≤ 24 weeks’
gestation) following prenatal diagnosis because of a con-
genital malformation, stillbirths (foetuses of ≥ 24 weeks’
gestation), live births, and children diagnosed before
11 years of age.
Cases are reported by general practitioners, midwives
and physicians [27]. Hospital registries are also actively
and regularly searched by the EUROCAT-NNL personnel
to find eligible children/pregnancies. Various sources in-
cluding hospital files, obstetric and pathology records
are searched for case assessment (type of malformation,
chronic diseases and dates of screening procedures).
When new information becomes available for an already
registered case, the case is updated in the EUROCAT-
NNL database until the child reaches the age of 11 years.
The paediatric cardiology centre (part of the University
Medical Centre Groningen) covers all births in the
EUROCAT-NNL registration area and supplies system-
atic lists with cases and diagnostic details to the registry
[28]. For all reported cases, results of genetic tests
are downloaded from the genetics department, if these
results are available. Abnormal karyotype reports are
recorded from prenatal and postnatal samples [28].Since 1992, parents or guardians are asked to give in-
formed consent for registration of their child and for the
use the data for research purposes. The response rate is
80%. Up to 1992, no parental approval was required to
register cases.
This study was approved by the Medical Ethical
Committee, University Medical Centre Groningen, the
Netherlands (number M12.118639).
Classification
EUROCAT adopted the International Classification of
Diseases (ICD-9), with modifications, from the British
Paediatric Association for births up to 2001, and the tenth
revision (ICD-10) from 2002 onwards [29,30]. The two
ICD guides were used to code cases into clinical and ana-
tomical types. There were three clinical types of CLD: (1)
isolated CLD, if the case only had one or more limb de-
fects but no other major congenital anomalies; (2) mul-
tiple congenital anomalies (MCA), if there was a limb
defect combined with at least one major non-limb defect
unrelated to a syndrome; or (3) CLD as part of a genetic
disorder or syndrome (recognised conditions). There were
four anatomical categories: polydactyly (ICD10-Q69 and
ICD9-7550), syndactyly (ICD10-Q70 and ICD9-7551,
7550.4), reduction defects (transverse, longitudinal, inter-
calary and central) (ICD10 Q71-73 and ICD9 7552-7554),
and “other CLD” (ICD10-Q74, ICD9-7555, 7556, 7558).
Split hand (ICD9 7555.11-7555.14) and split foot (ICD9
7556.12-7556.15) were considered central reduction
defects since they are coded as reduction defects in
ICD10. Proximal femoral focal deficiency (ICD10-
Q72.4, ICD9-7553.80) was classified as an intercalary
reduction defect of the lower limb. The “other CLD”
classification included limb anomalies like Sprengel’s
and Madelung’s deformity, macrodactyly, radioulnar
synostosis, hemihypertrophy, limb undergrowth, and
arthrogryposis multiplex congenita.
Study population
All children and foetuses with CLD, diagnosed before
or after birth, were included in this study. Children
with only minor CLD, such as clinodactyly, camptodac-
tyly, brachydactyly of the fourth and fifth fingers, trig-
ger finger, syndactyly of the second and third toes,
sandal gap, and short big toe were not included, be-
cause EUROCAT does not register minor CLD. We
also excluded malpositions, club foot and dislocation/
dysplasia of hips or knees (dislocation of patella) from
our analysis because these musculoskeletal anomalies
are common birth defects and their inclusion in the
calculations of total birth prevalence for CLD would
have given an inflated birth prevalence. The ICD-codes
were thoroughly checked against the descriptions of
CLD and rectified if necessary.
Table 1 Total birth prevalence per type of congenital limb defects for the period 1981–2010 in the northern Netherlands
CLD Isolated CLD, n Multiple congenital
anomalies, n




Polydactyly 291 45 83 419 8.4
Upper limb 228 38 63a 329 6.6
Preaxial 73 13 20 106 2.1
Postaxial 141 21 39 201 4.0
NOS 14 4 6 24 0.5
Lower limb 75 9 32 116 2.3
Preaxial 12 1 8 21 0.4
Postaxial 59 7 19 85 1.7
NOS 4 1 5 10 0.2
NOS 4 0 2 6 0.1
Upper and lower limb 16 2 14 32 0.6
Reduction defects 180 42 120 342 6.9
Upper limb 128 28 94 250 5.0
Transverse 89 17 39 145 2.9
Longitudinal 21b 9 51 81 1.6
Preaxial 12 7 33 52 1.0
Postaxial 10 2 18 30 0.6
Intercalary 3 1 5 9 0.2
Central 16 1 4 21 0.4
Multiple 1 0 5 6 0.1
Lower limb 66 25 58 149 3.0
Transverse 29 15 31 75 1.5
Longitudinal 23c 5 24 52 1.0
Preaxial 4 3 9 16 0.3
Postaxial 21 2 16 39 0.8
Intercalary 7 5 10 22 0.4
Central 13 1 2 16 0.3
Multiple 7 2 8d 17 0.3
NOS 1 1 0 2 0.04
NOS 0 0 1 1 0.02
Upper and lower limb 14 11 33 58 1.2
Syndactyly 126 29 77 232 4.7
Upper limb 77 17 46 140 2.8
Lower limb 59 12 46 117 2.4
NOS 0 1 0 1 0.02
Upper and lower limb 10 1 15 26 0.5
Other CLDe 41 34 88 163 3.3
Upper limb 18 14 66 98 2.0
Lower limb 25 22 53 100 2.0
NOS 0 1 0 1 0.02
Upper and lower limb 2 3 31 36 0.7
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Table 1 Total birth prevalence per type of congenital limb defects for the period 1981–2010 in the northern Netherlands
(Continued)
Multiple CLDf 38g 14g 49g 101 2.0
Total no. of cases 598 135 315 1048 21.1
Total no. of live births 587 77 159 823 16.5
Total number of births for the period 1981–2010: n = 497,751.
Abbreviations: CLD–congenital limb defects, NOS–not otherwise specified, n–number of children with CLD.
aTwo children had preaxial and postaxial polydactyly of upper limbs.
bOne child had preaxial and postaxial longitudinal reduction defects of upper limbs.
cTwo children had preaxial and postaxial longitudinal reduction defects of lower limbs.
dOne child had transversal, longitudinal and intercalary reduction defects of lower limbs.
eThe category consisted of CLD like arthrogryposis (n = 40), hemihypertrophy (n = 25), contractures of elbows/knees/fingers (n = 19), undergrowth of limbs (n = 9),
radio-ulnar synostosis (n = 5), macrodactyly (n = 4).
fCategory containing cases with several CLD included in the study.
gChildren in the group with isolated (n = 2), multiple congenital anomalies (n = 1), and CLD as part of a recognised condition (n = 4) had three types of CLD,
whereas the rest of the children with multiple limb defects had two types of CLD.
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dren with isolated CLD and MCA (non-syndromic
CLD). Because the registration method changed in
1992 with the introduction of informed consent, the
trend analysis was conducted for the period 1992–
2010. Localisation of the CLD (left/right side) was only
studied in live births with isolated CLD or MCA, be-
cause of possible lack of information on localisation
in stillbirths and spontaneous abortions or termination
of pregnancies. Syndromic CLD were excluded from
the laterality analysis because they have characteristicFigure 1 Overview of population included in the northern Netherland
MCA–multiple congenital anomalies, n–number of children with CLD.patterns [31]. We determined the most frequent anomalies
in other organ-systems that occurred in combination
with CLD (MCA cases). A clinical geneticist reviewed
the cases that were suspected of having monogenic or
genetic causality based on the description of the CLD,
associated anomalies, and/or family history.
Statistical analyses
BPs were determined by dividing the number of
affected cases by the total number of births (live births, still-
births, spontaneous abortions/termination of pregnancies)s study. Abbreviations and notations: CLD–congenital limb defects,
Table 2 Description of the recognised conditions with congenital limb defects (CLD)
Recognised condition CLD, n Type of CLD and the number of cases
Chromosomal 96
Trisomy 13, Patau 29 Polydactyly: Preax. LL = 1, Postax. UL = 19 and LL = 6, NOS UL = 4 and LL = 3
Syndactyly LL = 1
Trisomy 18, Edwards 24 Polydactyly: Preax. UL = 2, Postax. UL = 3
Reduction: Transv. UL = 1 and LL = 1, Preax. UL = 7 (radius aplasia, thumb aplasia/hypoplasia) and
LL = 1, Postax. UL = 2
Syndactyly: UL = 2, LL = 5
Other CLD: UL = 3, LL = 3
Triploidy 69 11 Polydactyly Preax. UL = 1
Syndactyly: UL = 7, LL = 8
Other CLD LL = 1 (shortening toes)
Trisomy 21, Down 6 Polydactyly Preax. LL = 1
Syndactyly: UL = 2, LL = 3
Trisomy 13, translocation 3 Polydactyly: Postax. UL = 2 and LL = 1, NOS UL = 1 and LL = 1
Unlisted chromosomal anomalya 23
Monogenenic 103
Arthrogryposis with a known gene 12 Other CLD: UL = 12 and LL = 8 (joint contractions)
Greig syndrome 10 Polydactyly: Preax. UL = 3 and LL = 7, Postax. UL = 4 and LL = 1
Syndactyly UL = 2, LL = 6
Holt-Oram syndrome 7 Polydactyly Preax. UL = 3 (triphalangeal thumb)
Reduction Preax. UL = 4 (radius aplasia/dysplasia)
Apert syndrome 5 Polydatyly Preax. UL = 1
Syndactyly: UL = 4 (3 digits II-V, 1 all digits), LL = 3 (all digits)
Other CLD = 2
Cornelia de Lange syndrome 5 Reduction: Transv. UL = 4 (bilateral), Postax. LL = 1, Central UL = 1 (split hand)
Syndactyly LL = 1
Other UL = 3 (all monodactyly)
Bardet-Biedl syndrome 4 Polydactyly: Postax. UL = 3 (bilateral) and LL = 3 (2 bilateral)
Reduction Transv. LL = 1
Thanatophoric dysplasia/dwarfism 3 Reduction: Transv. UL = 1 and LL = 1, Intercalary UL = 2 and LL = 2
Meckel-Gruber syndrome 3 Polydactyly: Postax. UL = 2 (1 bilateral) and LL = 2 (bilateral)
Syndactyly: LL = 1 (bilateral)
Peters plus syndrome 3 Reduction: Transv. UL = 2 (short UL) and LL = 1 (short LL), Intercalary LL = 1 (reduction of
femur bilateral);
Unlisted monogenica anomaly 51
Deletions 9 Polydactyly: Preax. UL = 1, Postax. UL = 1
Reduction: Transv. UL = 1 and LL = 1, Intercalary UL = 1 and LL = 1, Central UL = 1 (split hand) and
LL = 1 (split foot)
Syndactyly: UL = 1, LL = 3
Other recognised conditions 107
Amniotic bands 27 Reduction: Transv. UL = 14 and LL = 10, Preax. UL = 2 and LL = 6, Postax. UL = 5, Intercalary UL = 1
Syndactyly: UL = 9, LL = 4
Other CLD: UL = 4, LL = 5 (constriction bands)
Caudal regression syndrome 4 Reduction: Transv. UL = 1 and LL = 1, Preax. UL = 1 (atresia radius and thumb), Postax. LL = 1
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Table 2 Description of the recognised conditions with congenital limb defects (CLD) (Continued)
Syndactyly UL = 1
Acardiacus 3 Reduction: Transv. UL = 1 and LL = 1, Postax. UL = 1 and LL = 1, NOS = 1
Syndactyly LL = 1
Femoral facial syndrome 3 Reduction Intercalary = 1 (femoral hypoplasia)
Syndactyly LL = 2
Other CLD = 1 (contractures elbows and knees)
Limb–body-wall complex 6 Reduction: Transv. UL = 1 and LL = 3 (right side), Intercalary UL = 1, Postax. LL = 2
Other CLD LL = 1
Oculo-auriculo-vertebral
spectrum
4 Polydactyly Preax. UL = 1
Reduction Transv. UL = 1
Other CLD: UL = 1 (Sprengel deformity), LL = 1 (hemihypertophy)
VATER/VACTERL association 13 Polydactyly: Preax. UL = 2, Postax. LL = 1
Reduction: Transv. UL = 1 and LL = 1, Preax. UL = 8 (radius aplasia with or without thumb agenesis/
hypoplasia), Central UL = 1 (split hand)
Other CLD LL = 1 (flexion-extension deformity)
Poland syndrome 4 Reduction: Preax. UL = 2 (radius aplasia/dysplasia and thumb aplasia), Intercalary UL = 1
Syndactyly UL = 3
Foetal valproate syndrome 3 Polydactyly Preax. UL = 1
Reduction Preax. UL = 2 (radius aplasia)
Syndactyly UL = 1
Arthrogryposis multiplex
congenitab
14 Other CLD: UL = 14 (joints contractures), LL = 11 (joints contractures)
Femur-Fibula-Ulna complex 9 Reduction: Transv. LL = 1, Preax. LL = 1, Postax. UL = 5 (ulna hypoplasia, missing fingers) and LL = 8
(fibula aplasia, missing toes), Intercalary UL = 1 and LL = 4 (femur hypoplasia)
Syndactyly: UL = 3, LL = 2
Other CLD UL = 1
Klippel-Trenaunay-Weber
syndrome






Abbreviations: CLD–congenital limb defects, UL–upper limb, LL–lower limb, Transv.–transversal, Preax.–preaxial, Postax.–postaxial, n–number of children with CLD.
aRecognised conditions occurring in less than 3 cases are not listed in the table.
bUnknown gene.
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three-year moving average prevalence was calculated. The
χ2 test for trend was used to analyse changes over time
in BP and to determine whether a type of CLD was
preferentially associated with a congenital anomaly
affecting another organ system. Only MCA cases that
had one type of CLD were included in this analysis.
The association between the number of CLD and the
number of anomalies in other organ-systems was
tested for trend using the χ2 test. If χ2 assumptions (ex-
pected cell counts) were not met, the exact method
was used.
Two-tailed values of P < 0.05 were considered statisti-
cally significant. PASW Statistics 18.0 for Windows(SPSS Inc., 2009, Chicago, IL, www.spss.com) was used
for the analyses.
Results
Birth prevalence and study population
From 1981–2010, 1,048 cases with CLD were recorded
among 497,751 births in the northern Netherlands,
yielding a BP of 21.1/10,000 (Table 1). The prevalence
for transverse reduction defects was 3.9/10,000 births
and for longitudinal reduction defects 2.4/10,000 (equal
rates for preaxial and postaxial: 1.3/10,000).
Of the 1,048 cases, 823 (79%) were live-born chil-
dren; 181 (17%) were spontaneous abortions, stillbirths
or infants who died shortly after birth; and 44 (4%)
Figure 2 Time trends for non-syndromic congenital limb defects (isolated and MCA) for the period 1992–2010. MCA–multiple congenital
anomalies. Total limb defects: P for trend, 0.023; Polydactyly: P for trend, 0.574; Reduction defects: P for trend, 0.381; Syndactyly: P for trend, 0.009;
Other congenital limb defects (CLD): P for trend, 0.028.
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Table 3 Description of laterality in live-born children with a limb defecta
Right, Left, Bilateral, Total of sites,b
N (%) N (%) N (%) N (%)
Polydactyly (n = 322) 90 (13.6) 98 (14.8) 118 (17.8) 306 (46.1)
Upper limb 65 (9.8) 72 (10.8) 95 (14.3) 232 (34.9)
Lower limb 25 (3.8) 26 (3.9) 23 (3.5) 74 (11.1)
Syndactyly (n = 140) 40 (6.0) 49 (7.4) 44 (6.6) 133 (20.0)
Upper limb 24 (3.6) 29 (4.4) 26 (3.9) 79 (11.9)
Lower limb 16 (2.4) 20 (3.0) 18 (2.7) 54 (8.1)
Reduction defects (n = 193) 78 (11.7) 88 (13.3) 34 (5.1) 200 (30.1)
Upper limb 52 (7.8) 67 (10.1) 14 (2.1) 133 (20.0)
Transverse 38 (5.7) 49 (7.4) 7 (1.1) 94 (14.2)
Longitudinal 8 (1.2) 9 (1.4) 6 (0.9) 23 (3.5)
Intercalary 0 2 (0.3) 0 2 (0.3)
Central 6 (0.9) 7 (1.1) 1 (0.2) 14 (2.1)
Lower limb 26 (3.9) 21 (3.2) 20 (3.0) 67 (10.1)
Transverse 10 (1.5) 10 (1.5) 10 (1.5) 30 (4.5)
Longitudinal 10 (1.5) 9 (1.4) 3 (0.5) 22 (3.3)
Intercalary 3 (0.5) 1 (0.2) 0 4 (0.6)
Central 3 (0.5) 1 (0.2) 7 (1.1) 11 (1.7)
Other CLD (n = 58) 18 (2.7) 32 (4.8) 9 (1.4) 59 (8.9)
Upper limb 5 (0.8) 14 (2.1) 4 (0.6) 23 (3.5)
Lower limb 13 (2.0) 18 (2.7) 5 (0.8) 36 (5.4)
Total CLD (n = 664) 226 (34.0) 267 (40.2) 205 (30.9) 698 (105.1)
Upper limb 146 (22.0) 182 (27.4) 139 (20.9) 467 (70.3)
Lower limb 80 (12.0) 85 (12.8) 66 (9.9) 231 (34.8)
Abbreviations and notations: CLD–congenital limb defects, N–number of sites.
Percentages are calculated from the total number of children with isolated CLD and multiple congenital anomalies (n = 664). In 58 infants localisation
was unknown.
aIncluded only live births with isolated and multiple congenital defects (including a limb defect) because of 1) lack of information on stillbirths and abortions, and
2) genetic abnormalities or syndromes have characteristic patterns [31].
bNumber of sites exceeds the number of children due to multiple CLD in some cases.
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578 (55%) were males and 4 were of undetermined
gender. More males (455/823; 55%) were also regis-
tered in the live births. An overview of the data is
given in Figure 1.
Classification
There were 598 (57%) isolated CLD cases and 135 (13%)
MCA cases (Table 1). The remaining 315 (30% of total)
cases had a recognised condition, which included 96
chromosomal defects (31%), 103 monogenic defects
(33%), 9 deletions (3%), and 107 other recognised condi-
tions (34%) (Table 2). Trisomy 13 (n = 29; 30% of chromo-
somal defects) and trisomy 18 (n = 24; 25%) were found
most often in the cases with chromosomal abnormalities.
Cases with trisomy 13 most often had postaxial polydac-
tyly of an upper limb (n = 19), while the monogenic abnor-
malities contained, for example, cases with arthrogryposiswith a known gene (n = 12), Greig syndrome (n = 10), and
Holt-Oram syndrome (n = 7). Other recognised conditions
were mainly amniotic bands (n = 27, 25%), of which most
of the cases had transverse reduction defects (14 upper
limb, 10 lower limb) and syndactyly (9 upper limb, 4 lower
limb), arthrogryposis (n = 14, 13%) and VATER/VACTERL
association (vertebral defects, anal atresia, cardiac anomal-
ies, tracheo-oesophageal fistula with oesophageal atresia,
renal dysplasia, limb defects (n = 13, 12%)).
In this study, termination of pregnancy was performed in
44 cases. Isolated CLD occurred in 2 of the 44 cases (split
hands and feet; mixed reduction defects of the lower limb),
MCA in 15 (CLD with one or more other major non-CLD
defects: CNS and neural tube defects (n = 5), urinary
(n = 5), digestive system (n = 4), cardiovascular (n = 3), re-
spiratory system (n = 3)), and recognized conditions in 27
(chromosomal (n = 14), other recognized condition (n = 7),
and monogenic (n = 6)).
Table 4 Anomalies in other organ systems occurring with congenital limb defectsa
Anomalies Polydactyly Syndactyly Total reduction defects Other CLD Total
CLDc
(n = 45) (n = 29) (n = 42) (n = 34) (n = 135)
Totalb, n (%) Preax Postax n (%) Totalb, n (%) Transv Preax Postax Intercal Total, n (%) n (%)
CNS and neural tube defects 6 (4.4) 1 4 8 (5.9) 10 (7.4) 7 5 0 0 6 (4.4) 27 (20.0)
Hydrocephaly 1 (0.7) 0 0 5 (3.7) 3 (2.2) 2 2 0 0 3 (2.2) 10 (7.4)
Microcephaly 0 0 0 1 (0.7) 4 (3.0) 3 2 0 0 0 4 (3.0)
Eye 0 0 0 5 (3.7) 2 (1.5) 1 0 1 0 3 (2.2) 9 (6.7)
Ear 2 (1.5) 1 1 1 (0.7) 1 (0.7) 1 0 0 0 1 (0.7) 4 (3.0)
Cardiovascular 19 (14.1) 9 9 7 (5.2) 16 (11.9) 9 6 1 2 17 (12.6) 50 (37.0)
Tetralogy of Fallot 2 (1.5) 2 0 0 2 (1.5) 2 0 0 0 2 (1.5) 6 (4.44)
Atrium septum defects 1 (0.7) 1 0 1 (0.7) 3 (2.2) 2 1 0 0 3 (2.2) 7 (5.2)
Ventricular septum defects 8 (5.9) 4 3 4 (3.0) 6 (4.4) 2 3 1 2 6 (4.4 19 (14.1)
Coarctation aortae 2 (1.5) 0 2 0 1 (0.7) 0 1 0 0 1 (0.7) 4 (3.0)
Respiratory 8 (5.9) 2 4 3 (2.2) 5 (3.7) 2 3 0 0 6 (4.4) 19 (14.1)
Choanal atresia 3 (2.2) 0 2 0 0 0 0 0 0 0 3 (2.2)
Lung hypoplasia 1 (0.7) 0 0 1 (0.7) 0 0 0 0 0 4 (3.0) 5 (3.7)
Clefts 7 (5.2) 2 4 5 (3.7) 3 (2.2) 1 2 0 0 2 (1.5) 15 (11.1)
Cleft palate 3 (2,2) 0 3 3 (2.2) 2 (1.5) 1 1 0 0 1 (0.7) 8 (5.9)
Cleft lip 2 (1.5) 0 1 0 1 (0.7) 0 1 0 0 0 3 (2.2)
Digestive 8 (5.9) 1 6 3 (2.2) 14 (10.4) 8 5 1 0 3 (2.2) 25 (18.5)
Malformations of
oesophagus
0 0 0 0 4 (3.0) 2 0 0 0 0 4 (3.0)
Atresia/stenosis large
intestine
2 (1.5) 0 2 0 5 (3.7) 3 2 0 0 0 7 (5.2)
Anorectal atresia 2 (1.5) 0 2 0 5 (3.7) 3 2 0 0 0 7 (5.2)
Genital 6 (4.4) 0 6 3 (2.2) 10 (7.4) 6 4 0 0 4 (3.0) 23 (17.0)
Female 1 (0.7) 0 1 0 4 (3.0) 1 2 0 0 0 5 (3.7)
Male 5 (3.7) 0 5 3 (2.2) 5 (3.7) 3 1 0 0 4 (3.0) 17 (12.6)
Hypospadias 4 (3.0) 0 4 3 (2.2) 3 (2.2) 2 1 0 0 2 (1.5) 12 (8.9)
Urinary 6 (4.4) 1 3 10 (7.4) 13 (9.6) 6 6 1 1 8 (5.9) 34 (25.2)
Renal agenesis (uni/bilateral) 3 (2.2) 1 1 1 (0.7) 7 (5.2) 5 3 1 0 1 (0.7) 12 (8.9)
Cystic kidney 0 0 0 1 (0.7) 3 (2.2) 1 2 0 1 1 (0.7) 5 (3.7)
Potter sequence 0 0 0 1 (0.7) 2 (1.5) 1 2 0 0 1 (0.7) 4 (3.0)
Hydronephrosis 1 (0.7) 0 0 2 (1.5) 0 0 0 0 0 2 (1.5) 5 (3.7)
Horseshoe kidney 0 0 0 1 (0.7) 1 (0.7) 0 0 0 0 3 (2.2) 4 (3.0)
Abdominal wall defects 2 (1.5) 0 1 0 1 (0.7) 1 0 0 0 2 (1.5) 5 (3.7)
Omphalocele 1 (0.7) 0 1 0 1 (0.7) 1 0 0 0 2 (1.5) 4 (3.0)
Other 4 (3.0) 2 2 3 (2.2) 2 (1.5) 2 0 0 0 4 (3.0) 12 (8.9)
Abbreviations and notations: CLD–congenital limb defects, CNS–central nervous system, Transv–transversal, Preax–preaxial, Postax–postaxial, Intercal–intercalary,
n–number of children with CLD.
aOnly cases with multiple congenital anomalies (including a limb defect) were included because genetic abnormalities or syndromes have particular associations
[17]. General categories and examples of anomalies occurring with CLD were given.
bNumbers do not always add up due to multiple CLD in some cases or due to lack of information on subcategories of CLD (e.g. preaxial, postaxial). Percentages
are calculated from the total number of children with multiple congenital anomalies and CLD (n = 135).
cIn addition to one or several major non-limb defects, 24 cases (17.8%) also had a malposition, or a clubfoot, or hip dysplasia/dislocation (polydactyly n = 1,
syndactyly n = 8, reduction defects n = 9, other CLD n = 12).
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Table 5 Associated anomalies with congenital limb defectsa
Anomalies Polydactyly Reduction defects Syndactyly Other CLD Total
n (%) n (%) n (%) n (%) n (%) χ2 P
Cardiovascular yes 15 (45.5) 9 (27.3) 1 (3.0) 8 (24.2) 33 (100) 1.98 0.160
no 25 (35.7) 21 (30.0) 14 (20.0) 10 (14.3) 70 (100)
Urinary anomalies yes 5 (21.7) 9 (39.1) 5 (21.7) 4 (17.4) 23 (100) 1.85 0.194#
no 35 (43.8) 21 (26.3) 10 (12.5) 14 (17.5) 80 (100)
CNS and neural tube defects yes 6 (31.6) 7 (36.8) 4 (21.1) 2 (10.5) 19 (100) 1.63 0.246#
no 34 (40.5) 23 (27.4) 11 (13.1) 16 (19.0) 84 (100)
Genital yes 6 (31.6) 8 (42.1) 2 (10.5) 3 (15.8) 19 (100) 1.09 0.354#
no 34 (40.5) 22 (26.2) 13 (15.5) 15 (17.9) 84 (100)
Digestive yes 7 (35.0) 11 (55.0) 1 (5.0) 1 (5.0) 20 (100) 6.23 0.016#*
no 33 (39.8) 19 (22.9) 14 (16.9) 17 (20.5) 83 (100)
Respiratory yes 7 (50.0) 4 (28.6) 0 3 (21.4) 14 (100) 0.52 0.514#
no 33 (37.1) 26 (29.2) 15 (16.9) 15 (16.9) 89 (100)
Clefts (palate, lip) yes 6 (54.5) 2 (18.2) 2 (18.2) 1 (9.1) 11 (100) 0.10 0.774#
no 34 (37.0) 28 (30.4) 13 (14.1) 17 (18.5) 92 (100)
Eye yes 0 1 (20.0) 2 (40.0) 2 (40.0) 5 (100) 0.10 0.838#
no 40 (40.8) 29 (29.6) 13 (13.3) 16 (16.3) 98 (100)
Ear yes 2 (66.7) 1 (33.3) 0 0 3 (100) 0.03 1.000#
no 38 (38.0) 29 (29.0) 15 (15.0) 18 (18.0) 100 (100)
Total cases per CLD type 40 (38.8) 30 (29.1) 15 (14.6) 18 (17.5) 103 (100)
Abbreviations and notations: CLD–congenital limb defects, n–number of children with CLD, CNS–central nervous system, χ2–test value, P–value showing the
significance of association of anomalies with limb defect.
aOnly MCA cases with multiple congenital anomalies that had one type of CLD were included in this analysis; cases with a CLD and a malposition, or hip
dysplasia/dislocation, or clubfoot were excluded from the analysis.
*Significant P value.
#Exact P values.
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A significant decrease of the BP rate over time was
found for non-syndromic CLD as a group and for
non-syndromic syndactyly in particular (CLD: χ2 = 5.2,
P = 0.023, syndactyly: χ2 = 6.8, P = 0.009) (Figure 2).
The decrease in non-syndromic syndactyly from 5.2/
10,000 to 1.1/10.000 births was also found to be re-
sponsible for the decrease of non-syndromic CLD as aTable 6 Birth prevalences per 10,000 births in six EUROCAT r
Registry Polydactyly Reduction
Ireland - Dublin 7.6 5.7
Denmark - Odense 7.8 8.2
France - Paris 13.8 8.0
Belgium - Hainaut 8.6 7.3
Italy - Emilia Romagna 8.1 5.4
Italy - Tuscany 7.2 5.2
Northern Netherlandsa 8.8 8.6
Northern Netherlandsb 8.4 6.9
aBirth prevalences for the northern Netherlands on the EUROCAT website differ from
of miscoding.
bBirth prevalences in this study.total group (CLD syndactyly excluded: χ2 = 1.5, P =
0.215). A significant decrease was also noticed in the
heterogeneous group of “other CLD” (χ2 = 4.8, P =
0.028). When we included recognised conditions in
the analysis, no trend was identified for syndactyly
(χ2 = 1.5, P = 0.218), but there was a significant de-
creasing trend present for CLD as a group (χ2 = 9.3,
P = 0.002).egistries for the period 1981-2010









the ones reported in this study due to thorough verification and corrections
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Upper limbs were more often affected than lower limbs
(upper:lower = 2:1). Upper versus lower limb ratios were
3:1 in polydactyly, 1.5:1 in syndactyly, and 2:1 in reduc-
tion defects (Table 3). Limb defects were more often
left-sided (left:right = 1.2:1).Associated anomalies
CLD were most common with cardiovascular anomalies
(Table 4): 19 ventricular septal defects (of which 8 cases
had polydactyly), 7 atrial septal defects, 6 tetralogy of
Fallot, and 4 coarctation of the aorta. Urinary tract
anomalies were also frequent: 12 bi- or unilateral renal
agenesis (of which 7 cases had reduction defects), 5
hydronephrosis, and 5 cystic kidney. Anomalies of the
central nervous system were found in fewer cases with
CLD: 10 cases of hydrocephaly (of which 5 had syndac-
tyly) and 4 of microcephaly. More males were affected in
cases with genital anomalies (n = 17, uniformly spread
between CLD) of which most were hypospadias (n = 14).
We only found a significant association between di-
gestive anomalies and CLD (P = 0.016). Reduction de-
fects were more likely to occur in combination with
digestive tract anomalies, whereas syndactyly and “other
CLD” were less likely to occur with such anomalies
(Table 5). We found no significant association between
the number of CLD and the number of anomalies in
other organ-systems (χ2 = 3.4, df 1, linear-by-linear asso-
ciation P = 0.067).Discussion
We aimed to describe the epidemiology of CLD in the
northern Netherlands. From 1981–2010, the birth preva-
lence of CLD was 21.1/10,000 births, which falls between
the BPs found in two other European registries: Finland
(13/10,000 for 1964–1977) and Scotland (30.4/10,000 for
1964–1968) [9,10]. However, there were differences in
the inclusion criteria of all three registries.
More recent BPs for CLD are available on the official
website of the EUROCAT network of over thirty-seven
national registries [32]. These registries include live
births, stillbirths and terminations of pregnancies, which
allow their BPs for types of CLD to be compared with
the Netherlands (NNL). Six registries have reported
complete data for the period 1981–2010 (Dublin, Ireland;
Odense, Denmark; Paris, France; Hainaut, Belgium;
Emilia-Romagna and Tuscany, Italy).
Our BP for polydactyly (8.4/10,000) was close to the
figures reported for Emilia-Romagna and Hainaut (8.14
and 8.55; Table 6), but much lower that the BP in Paris
(13.8). We found a BP for syndactyly of 4.7/10,000,
which is comparable to that reported for Emilia-
Romagna (4.5) and Paris (5.1). Our BP for reductiondefects (6.9) was close to that reported by Hainaut (7.3;
Table 6).
The total BP of each EUROCAT registry includes the
club foot and hip dysplasia/dislocation, which hampers
direct comparison with the total BP determined in
our study (21.1/10,000). However, we can compare the
summed BPs for polydactyly, syndactyly and reduction
defects. Our calculated BP (20/10,000) is similar to those
calculated for Emilia-Romagna (18.0), Tuscany (18.6),
and Odense (22.2) (Table 6).
A literature review summarized the BPs of reduction
defects in different countries and time periods [23]. BPs
varied from 3.3 to 8.1 (in 1970) and to 5.0/10,000 in
Canada (Alberta, 1966–1975), from 6.6 to 4.8/10,000 in
USA (Atlanta, 1968–1993), and even to 10.4/10,000
births in France (1979–1987) [23]. The authors also
mentioned that the BPs of reduction defects may have
been underestimated in countries that excluded termina-
tions of pregnancies from their registries. The latest
advances in prenatal diagnosis are leading to more
terminations because of CLD [23]. In our NNL study,
the most common type of reduction defects were trans-
verse (3.9/10,000). Some studies reported similar preva-
lences for this type: France had 4.3/10,000 births for
1979–1987, Italy 2.6/10,000 for 1978–1987, and there
was a prevalence of 4.0/10,000 in six combined EURO-
CAT registries (Strasbourg, Belfast, Emilia Romagna,
Odense, Groningen, Basque Country) [13,19,24]. A re-
cent study in the USA found more longitudinal (3.5/
10,000 births) than transverse reduction defects (1.9/
10,000 births) for the periods 1972–1974 and 1979–
2000 [3].
The differences in BP between countries are most
likely to be the result of variations in coding methods,
ascertainment, notification and inclusion criteria and,
until a consistent and compatible system (such as that of
EUROCAT) is universally adopted, there will be no way
of determining whether BP variation has an environ-
mental or other cause.Localisation and laterality of limb defects
We found upper limbs were more commonly affected,
which agrees with the literature [9,13,23,33]. Left-sided
limb defects prevailed in our study, as in other studies
[9,14,24], but others have reported more right-sided de-
fects [16,34] or both sides being equally affected [35].
Longitudinal and multiple reduction defects were more
frequently localised on the right side [34].Gender distribution
Our male:female ratio for CLD was 1.2:1 in both total
births and in live births, compared with a male:female
ratio of 1.1:1 for live births in the northern Netherlands
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before, but its aetiology remains unexplained [17,19,37].
Trends
In the northern Netherlands, the BP of non-syndromic
syndactyly has shown a significant decrease since 1992.
EUROCAT-NNL has a reliable and well-established net-
work that notifies the registry of new cases shortly after
birth, ensuring that the parents of almost all children
with congenital anomalies in the region are contacted
for registration, thus we do not feel many cases will have
been missed. In addition, the diagnosis of syndactyly as
part of a genetic syndrome is more commonly detected
now than in the early 1990s. Excluding cases with
genetic syndromes from our time-trend analysis may
have influenced our finding of a drop in cases with non-
syndromic syndactyly over time. Another reason for
the decline might be a change in parental attitude to-
wards giving informed consent for registering syndactyly,
which might now be seen as a rather minor anomaly.
The introduction of the informed consent procedure in
1992 may also have influenced the number of registra-
tions compared to the period before 1992. In a post-hoc
analysis, no other significant trends were found for the
period 1981–1991. Finally, not all CLD cases may have
been reported yet. By including data from recent years
in our study, the decline may be due to the fact that
some of the cases still need to be registered. Therefore,
we cannot fully rule out that the decline observed is a
registration artefact.
Associated birth defects and recognised conditions
In comparison with polydactyly, syndactyly and “other
CLD”, we saw reduction defects more often in combin-
ation with congenital anomalies affecting the central
nervous system, digestive system (the only significant
association in current study, Table 5), genital or urinary
system. Associations of reduction defects with these
kinds of anomalies have been reported previously
[17,19,24]. However, in our study, reduction defects
were not the CLD type that occurred most frequently in
combination with cardiovascular anomalies, as seen in
other studies [17,19,24]. We found polydactyly (equally
preaxial and postaxial) occurred most often in combin-
ation with cardiovascular anomalies, especially with
ventricular septum defects. Another study reported
polydactyly occurring mostly with central nervous sys-
tem anomalies [38]. They also found significant associa-
tions of polydactyly with recognised syndromes: trisomy
13, Meckel, and Down syndrome [38]. We only found
trisomy 13 occurring often in our cases with postaxial
polydactyly of the upper limb.
In our NNL study, amniotic bands were the second
most frequently recognised condition after trisomy 13,and they also occurred more often in combination with
transversal limb defects and syndactyly, as reported in the
literature [34]. We also found syndactyly occurring often
with trisomy 18 (mostly syndactyly of lower limbs), Apert,
and Poland syndrome, also reported previously [39].
Longitudinal preaxial reduction defects were found to
be the most common reduction defects occurring in
cases with other congenital anomalies [17,34]. Preaxial
defects, for instance, can occur in the VATER association
and in many genetic conditions, while transverse defects
are usually isolated single defects in a family and may be
caused by disruptive events in early pregnancy [17,34].
We also found radius aplasia/dysplasia most frequently
in cases with VATER/VACTERL, trisomy 18, and Holt-
Oram syndrome.
To our knowledge, there are no genetic predisposi-
tions that are specific to the Dutch population that could
have influenced the birth prevalences of CLDs in this
study. In addition, the tables on the official EUROCAT
website did not reveal any particular recognized condi-
tion specific for the Netherlands compared to the other
six registries (Dublin, Ireland; Odense, Denmark; Paris,
France; Hainaut, Belgium; Emilia-Romagna, and Tuscany,
Italy) [32]. These observations, and the fact that our birth
prevalences of CLD are comparable to those in other
EUROCAT registries, imply that our birth prevalences
are relatively good estimates of world-wide preva-
lences. However, studies on larger populations with
CLD and with the same inclusion criteria would allow
for better generalizability.
Study strengths and limitations
The EUROCAT-NNL database contains specific and de-
tailed information about cases with birth defects. All the
cases were verified and corrected for any miscoding of
the CLD. Updated information, if available, was re-
trieved from the notifying hospital to clarify doubtful
coding or diagnosis.
Our data will be of clinical relevance to clinicians
treating children with CLD and to their parents, not
only the parents of live-born children who were unaware
of their child’s defect prior to delivery, but also the par-
ents who know they are expecting a child with a CLD.
The latter group is becoming more and more significant
with all the possibilities for information now offered by
prenatal diagnostics.
A limitation of our study may be the relatively small
number of children with MCA included in the analysis
for associations. The response rate for the parental con-
sent for the registration of their child is fairly high
(80%). Nevertheless, we cannot exclude the fact that
underestimation of the true BP of CLD may have oc-
curred. This type of underestimation, due to the volun-
tary participation of parents or notifying sources, is also
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Tuscany and Emilia-Romagna, Italy; Paris, France;
United Kingdom; Austria; Switzerland; Spain) [28]. A
further limitation may be the classification system
used. Although there are several classifications of CLD
[1,40,41] available, they all pose difficulties. The Inter-
national Federation of Societies for Surgery of the Hand
has adopted the morphological classification of Swanson
et al. [40]. However, this classification for CLD has not
been accepted by all surgeons [14], and difficulties based
on this classification have been reported [20]. Further-
more, Swanson’s classification is a more morphological
classification, and does not conform to the aim of our
study, which was to provide a descriptive overview of
CLD. Stoll et al. [42] proposed a purely descriptive clas-
sification of CLD, which complied with the purposes of
this article. However, Stoll et al.’s classification did not
allow for CLD that were included in the “other CLD”
category (e.g. arthrogryposis). We therefore used a clas-
sification based on ICD-9 and ICD-10 [29,30].
Conclusions
We established a prevalence of 21.1 children with CLD per
10,000 births in NNL after a thorough coding and correc-
tion procedure, which makes this figure reasonably reliable.
The decreasing trend observed in non-syndromic syndac-
tyly in 1992–2010 may be real or the result of a registration
artefact. CLD occurred frequently in combination with
cardiovascular and urinary tract anomalies, and were sig-
nificantly associated with digestive-tract anomalies.
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